Novo Nordisk

News

Agios shares slump on sickle cell disease data

Shares in Agios lost nearly half their value after it posted mixed clinical results from a phase 3 trial of its sickle cell disease therapy mitapivat.

News

Novo Nordisk cuts Wegovy price ahead of TrumpRx launch

Novo Nordisk has jumped the gun on US price reductions for its blockbuster diabetes and weight-loss drug semaglutide.

News

Pfizer, Metsera $10bn marriage back on after rough patch

Pfizer has won the battle for obesity drug developer Metsera, after rival Novo Nordisk said that it would not increase its bid above $10bn.

News

Company representatives with President Trump in the Oval Office

Novo, Lilly sign MFN pricing deal with Trump administration

The pricing agreement between Novo Nordisk and Eli Lilly and the Trump administration on GLP-1 drugs for diabetes and obesity has arrived.

News

Novo Nordisk fights back with oral GLP-1 data in obesity

Shortly after reporting weaker sales growth for its injectable GLP-1 drugs, Novo Nordisk has new data to help it stake a claim to the oral market.

News

Pfizer said to have matched Novo's $10bn bid for Metsera

The battle for obesity drug developer Metsera rumbles on, with Pfizer reported to have now matched Novo Nordisk's $10 billion offer.

Agios shares slump on sickle cell disease data

Novo Nordisk cuts Wegovy price ahead of TrumpRx launch

Pfizer, Metsera $10bn marriage back on after rough patch

Novo, Lilly sign MFN pricing deal with Trump administration

Novo Nordisk fights back with oral GLP-1 data in obesity

Pfizer said to have matched Novo's $10bn bid for Metsera

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Novo Nordisk

Editor's Picks